Evidence map›Paper›PMID 40464984›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2025

Asia-Pacific consensus for the management of osteoporosis in men.

Chun-Feng Huang, Cheng-Jung Ho, Sung-Yen Lin, Jawl-Shan Hwang, Ta-Wei Tai, Jung-Fu Chen, Shih-Te Tu, Ding-Cheng Chan, Rong-Sen Yang, Hsuan-Yu Chen and 42 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Consensus statement on the application of artificial intelligence in osteoporosis screening and management: perspectives from the Asia-Pacific region.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

52 authors.

Chun-Feng HuangFaculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Cheng-Jung HoOrthopedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
Sung-Yen LinOrthopedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
Jawl-Shan HwangDivision of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Ta-Wei TaiDepartment of Orthopedics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Jung-Fu ChenDivision of Metabolism and Endocrinology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Shih-Te TuDivision of Endocrinology and Metabolism, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.
Ding-Cheng ChanDepartment of Geriatrics and Gerontology, National Taiwan University Hospital, Taipei, Taiwan.
Rong-Sen YangDepartment of Orthopaedics, National Taiwan University Hospital, Taipei, Taiwan.
Hsuan-Yu ChenDepartment of Orthopaedics, National Taiwan University Hospital, Taipei, Taiwan.
Keh-Sung TsaiSuperintendent Office, Far Eastern Polyclinic of Far Eastern Medical Foundation, Taipei, Taiwan.
Tien-Tsai ChengDivision of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, College of Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, Kaohsiung, Taiwan.
Fang-Ping ChenKeelung Osteoporosis Prevention and Treatment Center, Chang Gung Memorial Hospital, Keelung, Taiwan.
Wei-Chieh HungDepartment of Family Medicine and Community Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Yin-Fan ChangDepartment of Family Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Der-Sheng HanDepartment of Physical Medicine and Rehabilitation, National Taiwan University Hospital, Bei-Hu Branch, Taipei, Taiwan.
Manju ChandranOsteoporosis and Bone Metabolism Unit, Singapore General Hospital, Singapore, Singapore.
Ang Seng BinDUKE NUS Medical School, Singapore, Singapore.
Joon Kiong LeeDepartment of Orthopedics, Beacon Hospital, Petaling Jaya, Malaysia.
Swan Sim YeapDivision of Rheumatology, Department of Medicine, Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia.
Yoon-Sok ChungDepartment of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Republic of Korea.
Kwang-Kyoun KimDepartment of Orthopedic Surgery, Konyang University College of Medicine, Daejeon, Republic of Korea.
Peter EbelingDepartment of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
Unnop JaisamrarnDepartment of Obstetrics and Gynecology, Chulalongkorn University, Bangkok, Thailand.
Dipendra PandeyDepartment of Orthopedics and Trauma Surgery, National Trauma Centre, National Academy of Medical Sciences, Kathmandu, Nepal.
Serge FerrariService of Bone Diseases, Department of Medicine, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland.
Eugene McCloskeyDivision of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.
Natthinee CharatcharoenwitthayaDivision of Endocrinology, Thammasat University, Bangkok, Thailand.
Akira TaguchiDepartment of Oral and Maxillofacial Radiology, Matsumoto Dental University, Shiojiri, Japan.
Sarath LekamwasamDepartment of Medicine, University of Ruhuna, Matara, Sri Lanka.
Tuan Van NguyenCentre for Health Technologies, University of Technology Sydney, Ultimo, Australia.
E Michael LewieckiNew Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA.
Kenneth G SaagUniversity of Alabama at Birmingham, Birmingham, AL, USA.
Ching-Chou TsaiDepartment of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Fernando MarínDepartment of Endocrinology, Quironsalud University Hospital, Madrid, Spain.
Satoshi MoriBone and Joint Surgery, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Kyu Ri HwangDepartment of Obstetrics & Gynecology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Julie Li-YuDepartment of Medicine, University of Santo Tomas Hospital, España, Manila, Philippines.
John J CareyDepartment of Medicine, University of Galway, Galway, Ireland.
David KendlerDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada.
Ching Lung CheungDepartment of Pharmacology and Pharmacy, The University of Hong Kong, Pok Fu Lam, Hong Kong, China.
Huei-Kai HuangDepartment of Family Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
Vilai KuptniratsaikulDepartment of Rehabilitation Medicine, Mahidol University, Salaya, Thailand.
Wing P ChanDepartment of Radiology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Siew Pheng ChanDivision of Endocrinology, Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Lan T Ho-PhamBioMedicine Research Center, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.
Fen Lee HewDivision of Endocrinology, Department of Medicine, Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia.
Huipeng ShiDepartment of Orthopedics, National Center for Orthopedics, Shanghai 6 Th People's Hospital, Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Ian ReidFaculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
John A KanisCentre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
Chung-Hwan Chen *Orthopedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chih-Hsing Wu *Department of Family Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. paulo@mail.ncku.edu.tw.ORCID http://orcid.org/0000-0002-0504-2053

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis in men is an underdiagnosed and undertreated condition that leads to significant morbidity and mortality, particularly in the aging population. This consensus report provides tailored guidelines for diagnosing, preventing, and treating male osteoporosis in the Asia-Pacific region by integrating global best practices with regional adaptations. PURPOSE: To establish evidence-based, region-specific guidelines for the management of male osteoporosis in the Asia-Pacific region, addressing demographic and lifestyle factors.

methodsExpert feedback was gathered through premeeting reviews, consensus conferences, and collaborative discussions. A life-course approach was employed to align international best practices with Asia-Pacific-specific needs, emphasizing continuous monitoring and intervention from middle age onward.

resultsThe 12 consensus strategies systematically approach male osteoporosis management, addressing screening, diagnosis, treatment, and long-term follow-up. Recommendations include the assessment of fracture risk for men aged 50 years and above, use of dual-energy X-ray absorptiometry (DXA) testing for men aged 70 years and above, lifestyle modifications, and pharmacological interventions such as bisphosphonates, denosumab, and anabolic agents for high-risk patients. Secondary causes of osteoporosis were highlighted, along with the establishment of fracture liaison services (FLSs) to improve long-term care. A life-course approach was proposed to optimize bone health throughout men's lives.

conclusionThis consensus provides a comprehensive framework tailored to the Asia-Pacific region for diagnosing, preventing, and managing osteoporosis in men. By addressing region-specific challenges and promoting evidence-based interventions, the latest guidelines incorporating the consensus may depict the conceptual direction in reducing fracture risk and improving long-term bone health outcomes for osteoporosis in men.

Indexed as

OsteoporosisAbsorptiometry, PhotonAgedAsiaBone DensityBone Density Conservation AgentsEvidence-Based MedicineHumansLife StyleMaleMass ScreeningMiddle AgedOsteoporotic FracturesRisk AssessmentBone Density Conservation AgentsAsia–Pacific regionconsensusfracturesMenosteoporosis

Identifiers

PMID40464984
PMCPMC12209010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.